Dr. Michael Jensen of Seattle Children’s has announced the FDA approval of the second pediatric leukemia T cell therapy, allowing patients between the ages of 12 months and 27 who have relapsed after bone marrow transplantation.
This allows for treatment on an accelerated basis with the latest version of reprogrammed T cells. For many children, this will be their last chance to beat their leukemia. Make Some Noise is excited and proud to continue to support this ground breaking kids’ cancer research.
